Analysis of malondialdehyde and ferric reducing ability of plasma in type 2 diabetes mellitus patients in Lucknow city, India

Background: The incidence and prevalence of type 2 diabetes mellitus (T2DM) is increasing due to obesity and sedentary lifestyles. Increased oxidative stress leads to oxidative damage of biomolecules and decreased antioxidant capacity. Aim: The study was designed to determine the malondialdehyde (M...

Full description

Saved in:
Bibliographic Details
Main Authors: Mohammad Zaid Kidwai, Roshan Alam, Haseeb Ahsan, Mohammad Mustufa Khan, Saba Khan
Format: Article
Language:English
Published: Indonesian Society for Biochemistry and Molecular Biology 2022-07-01
Series:Acta Biochimica Indonesiana
Subjects:
Online Access:https://pbbmi.org/newjurnal/index.php/actabioina/article/view/84
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1825199608230313984
author Mohammad Zaid Kidwai
Roshan Alam
Haseeb Ahsan
Mohammad Mustufa Khan
Saba Khan
author_facet Mohammad Zaid Kidwai
Roshan Alam
Haseeb Ahsan
Mohammad Mustufa Khan
Saba Khan
author_sort Mohammad Zaid Kidwai
collection DOAJ
description Background: The incidence and prevalence of type 2 diabetes mellitus (T2DM) is increasing due to obesity and sedentary lifestyles. Increased oxidative stress leads to oxidative damage of biomolecules and decreased antioxidant capacity. Aim: The study was designed to determine the malondialdehyde (MDA) and ferric reducing ability of plasma (FRAP) in T2DM patients at IIMS&R Hospital, Lucknow. Method: The oxidative stress was analyzed in T2DM patients as MDA. The total antioxidant capacity was estimated through the FRAP in T2DM patients and control subjects. Results: The level of MDA was observed to be higher (4.84 ± 1.09) in T2DM patients compared to controls (2.20 ± 0.85). The FRAP was lower among T2DM patients (509.46 ± 126.36) compared to controls (895.62 ± 179.92). The difference between FRAP in T2DM patients and controls was statistically significant (p=0.0001). Conclusion: MDA was found to be higher in T2DM, and the FRAP level was lower in T2DM patients compared to controls, signifying increased oxidative stress and decreased antioxidant level in T2DM patients.
format Article
id doaj-art-c491888e515e424c995eab4b11a0a01a
institution Kabale University
issn 2654-6108
2654-3222
language English
publishDate 2022-07-01
publisher Indonesian Society for Biochemistry and Molecular Biology
record_format Article
series Acta Biochimica Indonesiana
spelling doaj-art-c491888e515e424c995eab4b11a0a01a2025-02-08T03:06:01ZengIndonesian Society for Biochemistry and Molecular BiologyActa Biochimica Indonesiana2654-61082654-32222022-07-015110.32889/actabioina.84Analysis of malondialdehyde and ferric reducing ability of plasma in type 2 diabetes mellitus patients in Lucknow city, IndiaMohammad Zaid Kidwai0Roshan Alam1Haseeb Ahsan2Mohammad Mustufa Khan3Saba Khan4Department of Biochemistry, Integral Institute of Medical Sciences and Research, Integral University, Lucknow, IndiaDepartment of Biochemistry, Integral Institute of Medical Sciences and Research, Integral University, Lucknow, IndiaDepartment of Biochemistry, Faculty of Dentistry, Jamia Millia Islamia, Jamia Nagar, New Delhi, IndiaDepartment of Basic Medical Sciences, Integral Institute of Allied Health Sciences and Research, Integral University, Lucknow, IndiaDepartment of Biochemistry, Integral Institute of Medical Sciences and Research, Integral University, Lucknow, India Background: The incidence and prevalence of type 2 diabetes mellitus (T2DM) is increasing due to obesity and sedentary lifestyles. Increased oxidative stress leads to oxidative damage of biomolecules and decreased antioxidant capacity. Aim: The study was designed to determine the malondialdehyde (MDA) and ferric reducing ability of plasma (FRAP) in T2DM patients at IIMS&R Hospital, Lucknow. Method: The oxidative stress was analyzed in T2DM patients as MDA. The total antioxidant capacity was estimated through the FRAP in T2DM patients and control subjects. Results: The level of MDA was observed to be higher (4.84 ± 1.09) in T2DM patients compared to controls (2.20 ± 0.85). The FRAP was lower among T2DM patients (509.46 ± 126.36) compared to controls (895.62 ± 179.92). The difference between FRAP in T2DM patients and controls was statistically significant (p=0.0001). Conclusion: MDA was found to be higher in T2DM, and the FRAP level was lower in T2DM patients compared to controls, signifying increased oxidative stress and decreased antioxidant level in T2DM patients. https://pbbmi.org/newjurnal/index.php/actabioina/article/view/84oxidative stressantioxidantferric reducing ability of plasmaFRAPMDAmalondialdehyde
spellingShingle Mohammad Zaid Kidwai
Roshan Alam
Haseeb Ahsan
Mohammad Mustufa Khan
Saba Khan
Analysis of malondialdehyde and ferric reducing ability of plasma in type 2 diabetes mellitus patients in Lucknow city, India
Acta Biochimica Indonesiana
oxidative stress
antioxidant
ferric reducing ability of plasma
FRAP
MDA
malondialdehyde
title Analysis of malondialdehyde and ferric reducing ability of plasma in type 2 diabetes mellitus patients in Lucknow city, India
title_full Analysis of malondialdehyde and ferric reducing ability of plasma in type 2 diabetes mellitus patients in Lucknow city, India
title_fullStr Analysis of malondialdehyde and ferric reducing ability of plasma in type 2 diabetes mellitus patients in Lucknow city, India
title_full_unstemmed Analysis of malondialdehyde and ferric reducing ability of plasma in type 2 diabetes mellitus patients in Lucknow city, India
title_short Analysis of malondialdehyde and ferric reducing ability of plasma in type 2 diabetes mellitus patients in Lucknow city, India
title_sort analysis of malondialdehyde and ferric reducing ability of plasma in type 2 diabetes mellitus patients in lucknow city india
topic oxidative stress
antioxidant
ferric reducing ability of plasma
FRAP
MDA
malondialdehyde
url https://pbbmi.org/newjurnal/index.php/actabioina/article/view/84
work_keys_str_mv AT mohammadzaidkidwai analysisofmalondialdehydeandferricreducingabilityofplasmaintype2diabetesmellituspatientsinlucknowcityindia
AT roshanalam analysisofmalondialdehydeandferricreducingabilityofplasmaintype2diabetesmellituspatientsinlucknowcityindia
AT haseebahsan analysisofmalondialdehydeandferricreducingabilityofplasmaintype2diabetesmellituspatientsinlucknowcityindia
AT mohammadmustufakhan analysisofmalondialdehydeandferricreducingabilityofplasmaintype2diabetesmellituspatientsinlucknowcityindia
AT sabakhan analysisofmalondialdehydeandferricreducingabilityofplasmaintype2diabetesmellituspatientsinlucknowcityindia